Gifford bioscience limited:1340014 [24-002110]
Ended Purchase Order Awarded Last action
- Contract number
- 75N95024P00187
- Awardee
-
Gifford Bioscience LIMITED UEI S5NXYF5SE3S1
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $12,655
Award facts
- Contract value 100% obligated
- $12,654.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Baltimore, MD 21224, USA
Award details come from SAM.gov/FPDS.
About this award
Gifford Bioscience Limited (GBL) was awarded a firm fixed price purchase order totaling $12,655 by the National Institutes of Health's National Institute on Drug Abuse. Under this contract, GBL will provide unspecified products or services in support of the National Institute on Drug Abuse's research efforts. Performance will occur in Baltimore, Maryland through March 2025. No set-aside provisions were applied to this award. GBL will act as the prime contractor on this contract.
Quick answers
Who was awarded contract 75N95024P00187?
75N95024P00187 was awarded to Gifford Bioscience LIMITED by National Institute on Drug Abuse (National Institutes of Health) on March 13, 2024.
How much is contract 75N95024P00187 worth?
The government has obligated $12,655 on 75N95024P00187.
Was contract 75N95024P00187 competed?
The extent of competition for 75N95024P00187 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award